滚动资讯
FierceBiotechMirum maps FDA path after anti-itch candidate scores ph. 2 winNovartisAfter March cuts, Novartis trims another 60 roles at US headquarters - Fierce PharmaFierceBiotechTakeda pivotal trial win improves convenience for PID patients relative to HyQviaBioWorldBiggest gainers and losers for April 27-May 1, 2026Endpoints NewsCelcuity breast cancer win; Odyssey plans $205M IPO; Latus Bio extends Series AFierceBiotechWindward获1.65亿美元融资，推动长效TSLP研发雄心Endpoints News生物科技迎来新型初创模式：小团队、高投资、中国资产Thermo Fisher赛默飞世尔科技推出Gibco CTS DynaXS一次性生物反应器PfizerPfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era - Yahoo FinanceSiemens HealthineersCDC HoST-TT Certification for Siemens Healthineers Total Testosterone Test Expands Patient Access to Gold Standard Equivalent Results - The Manila TimesSiemens HealthineersSiemens Healthineers testosterone assay maintains CDC certification By Investing.com - Investing.com CanadaPharmaVoiceArvinas获得里程碑式批准，蛋白质降解剂研发提速
FierceBiotech 2026年1月23日

百时美施贵宝从卫材挖角顶尖神经科学研究专家。

百时美施贵宝从卫材挖角顶尖神经科学研究专家。

原文
暂时没有全文，请查看原始来源。